Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
TEAM
|
Michael Cannon Brookes
CEO, Co-Founder |
SELL
Open market or private sale
|
Indirect | 7,665 Reduced 0.0% |
$1,267,944
$165.42 p/Share
|
Oct 27
2025 |
|
PSMT
|
Francisco Velasco
EVP - CLO, CRCO |
SELL
Payment of exercise price or tax liability
|
Direct | 5,787 Reduced 7.05% |
$712,669
$123.15 p/Share
|
Oct 27
2025 |
|
PEGA
|
Efstathios A Kouninis
SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 4,425 Reduced 95.55% |
$297,581
$67.25 p/Share
|
Oct 27
2025 |
|
PEGA
|
Efstathios A Kouninis
SVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 6,825 Reduced 59.58% |
$458,981
$67.25 p/Share
|
Oct 27
2025 |
|
PEGA
|
Efstathios A Kouninis
SVP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 11,250 Added 49.55% |
$265,950
$23.64 p/Share
|
Oct 27
2025 |
|
HIMS
|
Soleil Boughton
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 2,637 Reduced 1.64% |
$132,113
$50.1 p/Share
|
Oct 27
2025 |
|
MPLT
|
Christopher A. Kroeger
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 225,693 Added 50.0% |
-
|
Oct 27
2025 |
|
MPLT
|
Robert C. Malenka |
BUY
Grant, award, or other acquisition
|
Direct | 34,390 Added 7.92% |
-
|
Oct 27
2025 |
|
MPLT
|
Erin Pennock Foff
Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct | 48,275 Added 50.0% |
-
|
Oct 27
2025 |
|
MPLT
|
Setia Vishwas
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 43,367 Added 50.0% |
-
|
Oct 27
2025 |
|
MPLT
|
James Woodruff Lillie
Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct | 32,539 Added 50.0% |
-
|
Oct 27
2025 |
|
MPLT
|
Anatol Kreitzer
Chief Discovery Officer |
BUY
Grant, award, or other acquisition
|
Direct | 35,953 Added 50.0% |
-
|
Oct 27
2025 |
|
MPLT
|
Jonathan Gillis
CAAO and PAO |
BUY
Grant, award, or other acquisition
|
Direct | 30,565 Added 50.0% |
-
|
Oct 27
2025 |
|
MPLT
|
Kristopher Hanson
General Counsel |
BUY
Grant, award, or other acquisition
|
Direct | 27,098 Added 50.0% |
-
|
Oct 27
2025 |
|
WSBF
|
Michael L Hansen
Director |
SELL
Open market or private sale
|
Direct | 79,872 Reduced 100.0% |
$1,210,859
$15.16 p/Share
|
Oct 27
2025 |
|
WSBF
|
Michael L Hansen
Director |
SELL
Open market or private sale
|
Indirect | 1,541 Reduced 0.0% |
$23,361
$15.16 p/Share
|
Oct 27
2025 |
|
MPLT
|
Maria C Walker |
BUY
Grant, award, or other acquisition
|
Direct | 6,294 Added 50.0% |
-
|
Oct 27
2025 |
|
MPLT
|
Timothy John Garnett |
BUY
Grant, award, or other acquisition
|
Direct | 6,294 Added 50.0% |
-
|
Oct 27
2025 |
|
BSY
|
Brock Ballard
Chief Revenue Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 609 Reduced 0.89% |
$31,789
$52.2 p/Share
|
Oct 27
2025 |
|
BL
|
Thomas Unterman
Director |
SELL
Open market or private sale
|
Indirect | 910 Reduced 0.0% |
$50,050
$55.0 p/Share
|
Oct 27
2025 |
|
TNL
|
Geoffrey Richards
Officer |
SELL
Open market or private sale
|
Indirect | 26,838 Reduced 0.0% |
$1,772,918
$66.06 p/Share
|
Oct 27
2025 |
|
MRSN
|
Mohan Bala
SVP, Chief Development Officer |
SELL
Open market or private sale
|
Direct | 77 Reduced 2.57% |
$762
$9.9 p/Share
|
Oct 27
2025 |
|
EFX
|
Jamil Farshchi
EVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 4,925 Reduced 11.12% |
$1,176,779
$238.94 p/Share
|
Oct 27
2025 |
|
EFX
|
Jamil Farshchi
EVP, Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 4,925 Added 10.01% |
$864,239
$175.48 p/Share
|
Oct 27
2025 |
|
NTRS
|
Robert Edward Moritz Jr.
Director |
BUY
Open market or private purchase
|
Direct | 270 Added 8.81% |
$34,198
$126.66 p/Share
|
Oct 27
2025 |
|
ALIS
|
Dahe Zhang
> 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Indirect | 99,000 Reduced 0.0% |
-
|
Oct 27
2025 |
|
CFG
|
Aunoy Banerjee
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 67,424 Added 50.0% |
-
|
Oct 27
2025 |
|
ALIS
|
Na Gai
Chairwoman of the Board |
SELL
Sale (or disposition) back to the issuer
|
Indirect | 201,000 Reduced 0.0% |
-
|
Oct 27
2025 |
|
UCBI
|
Richard Bradshaw
EVP, Chief Banking Officer |
SELL
Open market or private sale
|
Direct | 1,654 Reduced 2.15% |
$50,000
$30.23 p/Share
|
Oct 27
2025 |
|
AGNC
|
Peter J Federico
Director, Pres., CEO and CIO |
SELL
Open market or private sale
|
Direct | 45,798 Reduced 2.86% |
$470,345
$10.27 p/Share
|
Oct 27
2025 |
|
DWSN
|
William Anthony Clark
CEO & President |
BUY
Grant, award, or other acquisition
|
Direct | 150,000 Added 49.69% |
-
|
Oct 27
2025 |
|
DWSN
|
Ray L Mays
EVP & Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct | 100,000 Added 47.96% |
-
|
Oct 27
2025 |
|
EVLV
|
Anil Chitkara
Founder & Chief Growth Officer |
SELL
Open market or private sale
|
Direct | 120,000 Reduced 8.6% |
$983,999
$8.2 p/Share
|
Oct 27
2025 |
|
EVLV
|
Anil Chitkara
Founder & Chief Growth Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 120,000 Added 7.92% |
$39,600
$0.33 p/Share
|
Oct 27
2025 |
|
TCBI
|
Robert W Stallings
Director |
BUY
Open market or private purchase
|
Indirect | 5,000 Added 0.0% |
$103,400
$20.68 p/Share
|
Oct 27
2025 |
|
GGT
|
Mario J Gabelli
Director |
BUY
Open market or private purchase
|
Indirect | 31,000 Added 0.0% |
$125,240
$4.04 p/Share
|
Oct 27
2025 |
|
NEOG
|
Rafael A Rodriguez
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,777 Added 7.86% |
$10,999
$6.19 p/Share
|
Oct 27
2025 |
|
NEOG
|
James P Tobin
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,777 Added 3.94% |
$10,999
$6.19 p/Share
|
Oct 27
2025 |
|
FUL
|
John J Corkrean
Executive VP and CFO |
SELL
Open market or private sale
|
Direct | 14,222 Reduced 20.65% |
$857,728
$60.31 p/Share
|
Oct 27
2025 |
|
FUL
|
John J Corkrean
Executive VP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 16,672 Added 19.49% |
$724,898
$43.48 p/Share
|
Oct 27
2025 |
|
NEOG
|
Catherine E Woteki
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,777 Added 8.5% |
$10,999
$6.19 p/Share
|
Oct 27
2025 |
|
MLAB
|
Gary M Owens
President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 11,558 Added 15.27% |
-
|
Oct 27
2025 |
|
GF
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 5,633 Added 0.0% |
$63,314
$11.24 p/Share
|
Oct 27
2025 |
|
RVP
|
Thomas J Shaw
PRESIDENT AND CEO |
BUY
Open market or private purchase
|
Direct | 34,506 Added 0.22% |
$32,435
$0.94 p/Share
|
Oct 27
2025 |
|
NEOG
|
Amy M Rocklin
Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,085 Reduced 3.51% |
$12,906
$6.19 p/Share
|
Oct 27
2025 |
|
NEOG
|
Amy M Rocklin
Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 9,474 Added 13.77% |
$58,644
$6.19 p/Share
|
Oct 27
2025 |
|
NEOG
|
David H. Naemura
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 4,261 Reduced 5.0% |
$26,375
$6.19 p/Share
|
Oct 27
2025 |
|
NEOG
|
David H. Naemura
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 15,504 Added 15.38% |
$95,969
$6.19 p/Share
|
Oct 27
2025 |
|
AFB
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 25,686 Reduced 0.0% |
$282,289
$10.99 p/Share
|
Oct 27
2025 |
|
NSC
|
Richard H Anderson
Director |
BUY
Open market or private purchase
|
Indirect | 2,600 Added 0.0% |
$732,836
$281.86 p/Share
|
Oct 27
2025 |